Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: is angiographic vasospasm an epiphenomenon?
Vergouwen
Mervyn D I
MD
Vermeulen
Marinus
M
Roos
Yvo B W E M
YB
D002545:Brain Ischemia / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D002533:Cerebral Angiography; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D004146:Dioxanes / Q000627:therapeutic use; D023381:Endpoint Determination; D006801:Humans; D011725:Pyridines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013345:Subarachnoid Hemorrhage / Q000150:complications* / Q000473:pathology; D013449:Sulfonamides / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D020301:Vasospasm, Intracranial / Q000473:pathology*
D004146:Dioxanes; D011725:Pyridines; D011743:Pyrimidines; D013449:Sulfonamides; D013777:Tetrazoles; C109641:clazosentan